• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 前のページに戻る

Novel adjuvant method of malignant brain tumor neutron capture therapy with absorbed dose evaluation and tumor localization using composite boron and high-Z element nanoparticles.

研究課題

研究課題/領域番号 17K15797
研究種目

若手研究(B)

配分区分基金
研究分野 医学物理学・放射線技術学
研究機関筑波大学

研究代表者

ザボロノク アレクサンドル  筑波大学, 医学医療系, 助教 (20723117)

研究期間 (年度) 2017-04-01 – 2019-03-31
研究課題ステータス 交付 (2017年度)
配分額 *注記
2,990千円 (直接経費: 2,300千円、間接経費: 690千円)
2018年度: 1,690千円 (直接経費: 1,300千円、間接経費: 390千円)
2017年度: 1,300千円 (直接経費: 1,000千円、間接経費: 300千円)
キーワードBNCT / glioma / nanoparticles / boron / high-Z element
研究実績の概要

In 2017 fiscal year, the following stages of the main plan were accomplished. Composite boron and high-Z element (gold)-containing nanoparticles were synthesized by a new proposed method of cascade ultrasonic dispersion / destruction of micron particles (analyzed by X-ray crystallography) in an aqueous medium. Optical characteristics were analyzed by the light absorption and dynamic light scattering (DLS), showing particle size distribution, zeta-potential and the plasmon resonance. The particles were studied using transmission (TEM) and surface electronic microscopy (SEM). Elemental analysis was performed using inductively-coupled plasma atomic emission spectroscopy (ICP-AES). The efficacy of the accelerator-based neutron source was proven using human and animal tumor and normal cell lines by exponential decrease in colony formation with increase in boron concentration.The method of absorbed dose estimation using combination of boron and gold in tumor cells was tested using human glioma cells with incubated high-Z element nanoparticles and irradiated by epithermal neutrons in an acryl phantom to mimic real treatment conditions.Sample activation resulted in radioactive 198Au isotope generation which was utilized for absorbed dose calculations at each boron concentration.The overall cell-killing effect of the therapy was assessed by a colony-forming assay with evaluation of radiobiological parameters. The results of the study were presented at several conferences and included in scientific publications.

現在までの達成度 (区分)
現在までの達成度 (区分)

3: やや遅れている

理由

Implementation of the main plan was slightly delayed due to the limited machine time at the exclusive accelerator-based neutron source and initial procedures of development of absolutely unique nanoparticles, production method and evaluation of the product types prior to application in boron neutron therapy (BNCT) experiments.At the initial stage of the development of a nano-sized composite boron-high-Z-element-compound for BNCT, the funds were also partly spent on transportation to the accelerator-based neutron source as neutron irradiation was required for main stages of the study. Further publishing and manuscript-related costs are planned to be covered in the next fiscal year.

今後の研究の推進方策

The funds will be used according to the main plan of the study, including all preparatory stages of the study flow, with additional costs for publications, transferred to the next fiscal year.Further evaluation of the composite compounds presented as boron and high-Z element-containing nanoparticles in vivo for their toxicity, accumulation in tumor and normal tissues, the tumor/normal tissue accumulation ratio, tumor killing effect (decrease in size or disappearance of the tumor) and the effect on healthy tissues will be performed. Additionally, boron dose estimation in the irradiated tumor tissue and development of tumor localization using the properties of the high-Z element in the composite compounds will be done. Animal (rat and/or mouse) subcutaneous and/or brain tumor models of animal and human brain tumors are planned to be used. Selection of the most appropriate and less toxic compound with better accumulation in tumor tissues and higher tumor to normal tissue ratio, as well as better boron dose estimation properties is planned. Selection of more treatment-sensitive tumors for chosen compounds with further modification of the composite compounds to improve their functionality is planned to advance the research towards future clinical application.

報告書

(1件)
  • 2017 実施状況報告書

研究成果

(7件)

すべて 2018 2017

すべて 雑誌論文 学会発表

  • [雑誌論文] Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy.2018

    • 著者名/発表者名
      Sato Eisuke、Zaboronok Alexander、Yamamoto Tetsuya、Nakai Kei、Taskaev Sergey、Volkova Olga、Mechetina Ludmila、Taranin Alexander、Kanygin Vladimir、Isobe Tomonori、Mathis Bryan J、Matsumura Akira
    • 雑誌名

      Journal of Radiation Research

      巻: 59 ページ: 101-107

    • DOI
      10.1093/jrr/rrx071
    • NAID
      120006478280
    • 関連する報告書
      2017 実施状況報告書
    • 査読あり / オープンアクセスとしている / 国際共著/国際学会である
  • [雑誌論文] Polycomplexes of Hyaluronic Acid and Borates in a Solid State and Solution: Synthesis, Characterization and Perspectives of Application in Boron Neutron Capture Therapy.2018

    • 著者名/発表者名
      Zelenetskii Alexander、Uspenskii Sergey、Zaboronok Alexander、Cherkaev Georgij、Shchegolihin Alexander、Mathis Bryan、Selyanin Mikhail、Yamamoto Tetsuya、Matsumura Akira
    • 雑誌名

      Polymers

      巻: 10 ページ: 1-14

    • DOI
      10.3390/polym10020181
    • NAID
      120006462538
    • 関連する報告書
      2017 実施状況報告書
    • 査読あり / オープンアクセスとしている / 国際共著/国際学会である
  • [学会発表] Accelerator-based neutron capture therapy: pre-clinical evaluation and prospective clinical use.2017

    • 著者名/発表者名
      Zaboronok A, Kanygin V, Taskaev S, Volkova O, Mechetina L, Taranin A, Iarullina A, Kichigin A, Byvaltsev V, Sato E, Nakai K, Ishikawa E, Mathis BJ, Yamamoto T, Matsumura A.
    • 学会等名
      International Conference “Physics of Cancer: Interdisciplinary Problems and Clinical Applications”, Tomsk, Russian Federation, 2017.5.23-26
    • 関連する報告書
      2017 実施状況報告書
    • 国際共著/国際学会である / 招待講演
  • [学会発表] Accelerator-based neutron capture therapy for malignant glioma with in-sample dosimetry using gold nanoparticles2017

    • 著者名/発表者名
      Zaboronok A, Taskaev S, Kanygin V, Kasatov D, Makarov A, Volkova O, Mechetina L, Taranin A, Iarullina A, Nakai K, Sato E, Mathis BJ, Yamamoto T, Matsumura A.
    • 学会等名
      The 32nd Japan Neurosurgery English Forum, Saitama, Japan, 2017.7.14.
    • 関連する報告書
      2017 実施状況報告書
  • [学会発表] Perspectives of combined photodynamic diagnosis and accelerator-based neutron capture therapy of malignant glioma using photosensitizer- and 10B-containing liposomes.2017

    • 著者名/発表者名
      Zaboronok A, Taskaev S, Muhamadiyarov R, Kichigin A, Volkova O, Mechetina L, Sato E, Nakai K, Yamamoto T, Taranin A, Kanygin V, Mathis BJ, Matsumura A.
    • 学会等名
      17th Annual Congress of the Korean Photodynamic Association. Seoul National University Bundang Hospital, Healthcare Innovation Park. Seoul, South Korea. 2017.09.02.
    • 関連する報告書
      2017 実施状況報告書
    • 国際共著/国際学会である
  • [学会発表] Perspectives of a photosensitizer and 10B compound liposomal delivery for combined photodynamic diagnosis/therapy and accelerator-based neutron capture therapy for malignant gliomas.2017

    • 著者名/発表者名
      Zaboronok A, Taskaev S, Volkova O, Mechetina L, Kichigin A, Sato E, Nakai K, Yamamoto T, Taranin A, Kanygin V, Mathis BJ, Matsumura A.
    • 学会等名
      9th Young Researchers’ BNCT Meeting. Kyoto University Uji Obaku Plaza, Gokasho, Uji, Kyoto, Japan. 2017.11.13-15.
    • 関連する報告書
      2017 実施状況報告書
    • 国際共著/国際学会である
  • [学会発表] Boron neutron capture therapy for malignant glioma: our experience at the reactor and preclinical evaluation of an accelerator-based neutron source.2017

    • 著者名/発表者名
      Zaboronok AA, KanyginVV, Taskaev SYu, Volkova OYu, Mechetina LV, Taranin AV, Iarullina AI, Kichigin AI, Byvaltsev VA, Sato E, Nakai K, Zavjalov EL, Akulov AE, Ishikawa E, Mathis BJ, Yamamoto T, Matsumura A.
    • 学会等名
      I Congress of Eurasian Association of Pediatric Neurosurgeons. Minsk, Belarus. 2017.11.29-12.01.
    • 関連する報告書
      2017 実施状況報告書
    • 国際共著/国際学会である

URL: 

公開日: 2017-04-28   更新日: 2018-12-17  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi